← Back to Search

Positive Airway Pressure

Treatment group for Obstructive Sleep Apnea (OSA Trial)

Phase 1 & 2
Waitlist Available
Led By Kristen H Archbold, PhD, RN
Research Sponsored by University of Tennessee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-12 months
Awards & highlights

OSA Trial Summary

Obstructive sleep apnea is a problem for a large number of children and can result in problems with thinking patterns, behaviors and sleep if left untreated. Little is known about how positive airway pressure (PAP) therapy might help children who need treatment for obstructive sleep apnea. We will investigate how PAP therapy might be able to improve thinking patterns, behavior and sleep problems in children with obstructive sleep apnea.

Eligible Conditions
  • Obstructive Sleep Apnea

OSA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neurobehavioral and cognitive function

OSA Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Treatment groupActive Control1 Intervention
30 children will receive active treatment PAP, which consists of automatically adjusted air pressures that are delivered through the nasal interface device at levels which effectively treats the obstructive events.
Group II: Sham PAP therapyPlacebo Group1 Intervention
Sham PAP will be used with 30 children, and consists of continuous sub-therapeutic levels of air pressure (approximately 1 cm of water) that are delivered through the nasal interface device.

Find a Location

Who is running the clinical trial?

University of TennesseeLead Sponsor
189 Previous Clinical Trials
141,950 Total Patients Enrolled
Kristen H Archbold, PhD, RNPrincipal InvestigatorUniversity of Tennessee Health Science Center College of Nursing

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025